Sio Capital Management, LLC Myovant Sciences Ltd. Transaction History

Sio Capital Management, LLC

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$13.8 - $27.62 $139,380 - $278,962
-10,100 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$14.05 - $22.6 $141,905 - $228,260
10,100 New
10,100 $142,000
Q1 2018

May 15, 2018
SELL
$12.46 - $21.32 $910,252 - $1.56 Million
-73,054 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$11.37 - $16.4 $830,623 - $1.2 Million
73,054
73,054 $923,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email